Can income-based co-payment rates improve disparity? The case of the choice between brand-name and generic drugs

Can income-based co-payment rates improve disparity? The case of the choice between brand-name and generic drugs

Abstract Background Higher income population tend to prefer brand-name to generic drugs, which may cause disparity in access to brand-name drugs among income groups. A potential policy that can resolve such disparity is imposing a greater co-payment rate on high-income enrollees. However, the effect...

Full description

Bibliographic Details
Main Authors: Yuki Ito, Konan Hara, Byung-Kwang Yoo, Jun Tomio, Yasuki Kobayashi
Format: Article
Language:English
Published: BMC 2019-11-01
Series:BMC Health Services Research
Subjects:
Co-payment rate
Generic drugs
Disparity
Pharmaceuticals
Online Access:http://link.springer.com/article/10.1186/s12913-019-4598-8

Internet

http://link.springer.com/article/10.1186/s12913-019-4598-8

Similar Items